Biliary Atresia Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Biliary Atresia Treatment Market is estimated to be valued at US$ 910.7 million in 2021 and is expected to exhibit a CAGR of 7% during the forecast period 2022-2028.

Biliary atresia or hepatomegaly is an acquired disease of the liver. The disease is characterized by obstruction of the extrahepatic biliary tract, which obstructs the flow of bile from the liver to the gallbladder. This can lead to liver damage or cirrhosis, which can be fatal if not treated at an early stage. It occurs because the bile ducts do not develop normally in infants. Currently, there is no known cause of biliary atresia. However, various studies have shown that Reovirus 3 infection, congenital cytomegalovirus infection, and congenital malformations may be responsible for causing biliary atresia in humans. Some of the symptoms associated with biliary atresia are pale or clay-colored stools, jaundice, dark urine, slow or no weight gain, and mild hepatomegaly and splenomegaly. A widely used treatment regimen to treat biliary atresia may be drugs and surgical procedures, including bile acids, glucocorticoids, and antibiotics.

Market Segments

By Type

• Drug Treatment
• Surgery Treatment

By Application

• Hospital
• Clinic

Key Players

Major players operating in the global biliary atresia treatment market include AstraZeneca plc, Eisai Co., Ltd., Mirum Pharmaceuticals, Inc., Pfizer Inc., Albireo Pharma, Inc., Novartis AG, Alkem Labs, and Glenmark Pharmaceuticals

Scope of the Report

The research study analyzes the global Biliary Atresia Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Biliary Atresia Treatment Market Report

1. What was the Biliary Atresia Treatment Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Biliary Atresia Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Biliary Atresia Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.